Apelin, a Novel Adipocytokine, in Relation to Endothelial Function and Inflammation in Kidney Allograft Recipients

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3466-3469

  Malyszko, J ^a   Malyszko, J S ^a   Pawlak, K ^a   Wolczynski, S ^a   Mysliwiec, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; APELIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CALCIUM; CD146 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHATE; PLASMINOGEN ACTIVATOR INHIBITOR; RESISTIN; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALCIUM BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIUM; ENDOTHELIUM INJURY; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CORONARY DISEASE; CREATININE; ENDOTHELIUM, VASCULAR; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; LIPIDS; MIDDLE AGED; MYOCARDIAL CONTRACTION; VASODILATION;

EID: 57549107880     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.059     Document Type: Article

References (23)

1. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107 (2005) 198
2. Boucher J., Masri B., Daviaud D., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 (2005) 1764
3. Falcao-Pires I., and Leite-Moreira A.F. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 24 (2005) 1263
4. Charles C.J. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 5 (2007) 1
5. Malyszko J., Malyszko J.S., Kozminski P., et al. Apelin, a novel adipocytokine, and cardiac function in hemodialyzed patients: possible relations?. Am J Nephrol 26 (2006) 121
6. Sarnak M.J., and Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35 suppl 1 (2000) 117
7. Foldes G., Horkay F., Szokodi I., et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308 (2003) 480
8. Chen M.M., Ashley E.A., Deng D.X., et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 (2003) 1432
9. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134
10. Malyszko J., Malyszko J.S., Pawlak K., et al. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc 38 (2006) 3434
11. Malyszko J., Malyszko J.S., Kozminski P., et al. Elevated resistin is related to inflammation and residual renal function in hemodialyzed patients. Nephrology 12 (2007) 246
12. Ohmori R., Momiyama Y., Kato R., et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. Am Coll Cardiol 46 (2005) 379
13. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932
14. Sarnak M.J., and Levey A.S. Epidemiology of cardiac disease in dialysis patients. Semin Dial 12 (1999) 69
15. Rigatto C., Parfrey P., Foley R., et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13 (2002) 1084
16. Szokodi I., Tavi P., Foldes G., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91 (2002) 434
17. Kasai A., Shintani N., Oda M., et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325 (2004) 395
18. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430
19. Boucher J., Masri B., Daviaud D., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 (2005) 1764
20. Li L., Yang G., Li Q., et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 114 (2006) 544
21. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 89 (2001) 763
22. Codognotto M., Piccoli A., Zaninotto M., et al. Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. Am J Nephrol 27 (2007) 1
23. Sheikh A.Y., Chun H.J., Glassford A.J., et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 294 (2008) H88